MiniMed Group Inc (NASDAQ:MMED – Get Free Report)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $11.10 and last traded at $11.16, with a volume of 578097 shares. The stock had previously closed at $11.57.
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on MMED shares. Wells Fargo & Company started coverage on MiniMed Group in a report on Tuesday, March 31st. They issued an “overweight” rating and a $26.00 target price on the stock. Morgan Stanley started coverage on MiniMed Group in a report on Tuesday, March 31st. They issued an “overweight” rating and a $19.00 target price on the stock. Bank of America started coverage on MiniMed Group in a report on Tuesday, March 31st. They issued a “buy” rating and a $27.00 target price on the stock. Deutsche Bank Aktiengesellschaft started coverage on MiniMed Group in a report on Tuesday, March 31st. They issued a “buy” rating and a $20.00 target price on the stock. Finally, William Blair began coverage on MiniMed Group in a report on Tuesday, March 31st. They issued an “outperform” rating on the stock. Eleven research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $22.45.
View Our Latest Report on MiniMed Group
MiniMed Group Price Performance
MiniMed Group Company Profile
We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.
See Also
- Five stocks we like better than MiniMed Group
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for MiniMed Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MiniMed Group and related companies with MarketBeat.com's FREE daily email newsletter.
